January 12-15, 2026 | San Francisco Marriott Marquis, CA
Matisse Pharmaceuticals BV is a bio-pharmaceutical clinical stage company dedicated to develop a product portfolio of safe and innovative therapies targeting inflammation characterized by elevated levels of cell free cytotoxic histones.